Implementation outcomes associated with a value-based care model of comprehensive medication management in community pharmacies

被引:2
|
作者
Farley, Joel F. [1 ,4 ]
Blanchard, Carrie M. [2 ]
Sorge, Lindsay A. [1 ]
Rehrauer, Daniel J. [3 ]
Sorensen, Todd D. [1 ]
机构
[1] Univ Minnesota, Coll Pharm, Dept Pharmaceut Care & Hlth Syst, Minneapolis, MN USA
[2] North Carolina Dept Hlth & Human Serv, Immunizat Branch, Div Publ Hlth, Chapel Hill, NC USA
[3] HealthPartners, Medicat Therapy Management & Pharm Qual, Bloomington, MN USA
[4] Univ Minnesota, Coll Pharm, Dept Pharmaceut Care & Hlth Syst, 7-159D Weaver Densford Hall,308 Harvard S SE, Minneapolis, MN 55455 USA
关键词
PROGRAM;
D O I
10.1016/j.japh.2022.11.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Although the delivery of comprehensive medication management (CMM) in community pharmacies has been shown to improve health outcomes, inconsistent adoption hinders the benefit patients receive. Our objective was to examine the implementation of a novel valuebased care model and the impact of educational and coaching support for pharmacists on patient access to CMM. The underlying care model provides a payment for CMM services combined with incentives to document and improve clinical outcomes and patient engagement. Design: Cross-sectional study. Setting and participants: In addition to fee-for-service payments, performance-based incentives were provided to 12 participating pharmacy organizations to promote pharmacist documentation of clinical values (blood pressure and tobacco status for patients with vascular disease and additionally hemoglobin A1c [HbA1C] for patients with diabetes). To promote patient engagement, pharmacies that engaged a higher proportion of attributed patients received additional incentives. Outcome measures: Implementation outcomes included penetration (the proportion of eligible patients who received CMM), adoption (variation in penetration across organizations), and fidelity (documentation of all required clinical values). Comparisons were made using t-tests and chi-square testing. Results: Among 1240 eligible patients, 478 (35.8%) had documentation of any service by a participating pharmacist during a one-year implementation period. Using diabetes as an example, documentation was consistently highest for tobacco status (38.1%), followed by blood pressure (29.7%), and HbA1C (38.1%). CMM recipients on average were older, used more medication, and were more likely to have at least one comorbid condition than non-recipients. 41.8% of patients with vascular disease had documentation of both blood pressure and tobacco status while 24.4% of patients with diabetes had blood pressure, tobacco, and HbA1C documentation. Conclusions: Improving pharmacist access to a patient's medical records could help improve access to CMM services for patients under value-based care models that rely on patient targeting and clinical measurements. (c) 2022 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:893 / +
页数:7
相关论文
共 50 条
  • [31] Telemental Health Collaborative Care Medication Management: Implementation and Outcomes
    Das, Smita
    Wang, Jane
    Chen, Shih-Yin
    Chen, Connie E.
    TELEMEDICINE AND E-HEALTH, 2022, 28 (07) : 1035 - 1043
  • [32] The Active Implementation Frameworks: A roadmap for advancing implementation of Comprehensive Medication Management in Primary care
    Blanchard, Carrie
    Livet, Melanie
    Ward, Caryn
    Sorge, Lindsay
    Sorensen, Todd D.
    McClurg, Mary Roth
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2017, 13 (05): : 922 - 929
  • [33] Comprehensive value-based cancer care in India: Opportunities for systems strengthening
    Bhadelia, Afsan
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2021, 154 (02) : 329 - 337
  • [34] OUTCOMES-BASED ARRANGEMENTS IN VALUE-BASED CARE: AN ENGAGEMENT FRAMEWORK
    Nazareth, T.
    Yu, T.
    Brunken, C.
    Arcona, S.
    Sasane, R.
    Petrilla, A.
    Velez, E.
    Hughes, K. E.
    VALUE IN HEALTH, 2016, 19 (03) : A294 - A294
  • [35] Outcomes That Matter to Patients: ICHOM as a Catalyst for Value-Based Care
    Bright, Jennifer
    Wake, Kevin
    Witkowski, Mary Lynch
    Psacharopoulos, Daphne
    Heywood, Jamie
    Ingvar, Martin
    Larsson, Stefan
    NEJM CATALYST INNOVATIONS IN CARE DELIVERY, 2025,
  • [36] A 3D model for value-based care
    不详
    ANNALS OF FAMILY MEDICINE, 2022, 20 (01)
  • [37] Study on value-based model of products package management
    Liu, Ying
    Tao, Fengming
    Liu, Fei
    KNOWLEDGE ENTERPRISE: INTELLIGENT STRATEGIES IN PRODUCT DESIGN, MANUFACTURING, AND MANAGEMENT, 2006, 207 : 356 - +
  • [38] The Value-Based Model: Health Management Worth Exploring
    Hunter, Kent C.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2009, 1 (01) : 41 - 47
  • [39] Identification of factors for a successful implementation of medication reviews in community pharmacies: Using Positive Deviance in pharmaceutical care
    Isabell Waltering
    Oliver Schwalbe
    Georg Hempel
    International Journal of Clinical Pharmacy, 2022, 44 : 79 - 89
  • [40] The implementation of change model adds value to value-based healthcare: a qualitative study
    Nina Zipfel
    Paul B. van der Nat
    Benno J. W. M. Rensing
    Edgar J. Daeter
    Gert P. Westert
    A. Stef Groenewoud
    BMC Health Services Research, 19